Hassard James has filed 11 insider transactions across 1 company since March 2023.
Most recent transaction: a option exercise of 15000 shares of Crinetics Pharmaceuticals, Inc. ($CRNX) on July 05, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 5, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | M | Common Stock | 15000 | $19.73 | 44,259.0000 | 68,175,000 | 51.27% | 0.02% |
| July 5, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | S | Common Stock | 15000 | $44.08 | 29,259.0000 | 68,175,000 | 33.89% | 0.02% |
| July 5, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | M | Stock option (Right to Buy) | 15000 | $0.00 | 130,000.0000 | 68,175,000 | 10.34% | 0.02% |
| June 21, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | M | Common Stock | 15000 | $19.73 | 44,259.0000 | 68,175,000 | 51.27% | 0.02% |
| June 21, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | S | Common Stock | 15000 | $44.66 | 29,259.0000 | 68,175,000 | 33.89% | 0.02% |
| June 21, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | M | Stock option (Right to Buy) | 15000 | $0.00 | 145,000.0000 | 68,175,000 | 9.38% | 0.02% |
| March 18, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | F | Common Stock | 1741 | $38.14 | 29,259.0000 | 68,175,000 | 5.62% | 0.00% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | A | Common Stock | 17000 | $0.00 | 31,000.0000 | 68,175,000 | 121.43% | 0.02% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | A | Stock Option (right to buy) | 63000 | $0.00 | 63,000.0000 | 68,175,000 | 9999.99% | 0.09% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | A | Common Stock | 14000 | $0.00 | 14,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Hassard James | Chief Commercial Officer | A | Stock Option (right to buy) | 65250 | $0.00 | 65,250.0000 | 0 | 9999.99% | 0.00% |